Low global arginine bioavailability: a common phenomenon in pulmonary hypertension

Am J Physiol Lung Cell Mol Physiol. 2024 Apr 1;326(4):L514-L515. doi: 10.1152/ajplung.00026.2024.

Dunia Hatabah¹, Teresa De Marco², Dana P McGlothlin³, Mary Malloy^{4

5}, Loretta Z Reyes^{1

6}, Rawan Korman¹, Gregory J Kato⁷, Claudia R Morris^{1

6}

¹ Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States.
² Division of Cardiology, Department of Medicine, University of California, San Francisco, California, United States.
³ Kaiser Permanente San Francisco, San Francisco, California, United States.
⁴ Department of Medicine and Pediatrics, University of California, San Francisco, California, United States.
⁵ Cardiovascular Research Institute, University of California, San Francisco, California, United States.
⁶ Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia, United States.
⁷ Blood Science Consulting, Tilghman, Maryland, United States.

No abstract available

Keywords: arginine; pulmonary hypertension.

Publication types